AU Patent

AU2013259872B2 — Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

Assigned to Nicox Ophthalmics Inc · Expires 2018-06-28 · 8y expired

What this patent protects

The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and…

USPTO Abstract

The present invention further provides method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and/or preventing the signs and/or symptoms of disorders such as blepharitis, meibomian gland dysfunction or skin inflammation or a respiratory disease (e.g., asthma).

Drugs covered by this patent

Patent Metadata

Patent number
AU2013259872B2
Jurisdiction
AU
Classification
—
Expires
2018-06-28
Drug substance claim
No
Drug product claim
No
Assignee
Nicox Ophthalmics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.